DT-TUG Protocols: Checking if Three Ways to Do the Dual-Task Timed Up and Go Are Reliable
Official title: Comparison of the Reliability and Convergent Validity of Three Dual-Task Timed Up and Go Protocols in People With Multiple Sclerosis
Run by Afyonkarahisar Health Sciences University · NCT07788859 · Data updated 2026-11-12
This study tests three methods of the dual-task Timed Up and Go test to see which is most reliable for adults with multiple sclerosis.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 40 (estimated) |
| Sponsor | Afyonkarahisar Health Sciences University Academic / other |
| Locations | 1 site (Gaziantep) |
| Status | Recruiting |
| Started | March 16, 2026 |
| Main results expected | September 14, 2026 |
| Study ends | September 14, 2026 |
| Registry record updated | August 27, 2026 |
| Trial ID | NCT07788859 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18–65 with a confirmed MS diagnosis (McDonald criteria 2017), EDSS 0–5.5, able to walk without aids.
✕Probably not a fit
Individuals with higher disability (EDSS >5.5), recent relapse, or other neurological or sensory impairments may not benefit from these protocols.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study compares three dual-task Timed Up and Go protocols to determine their validity and reliability in people with multiple sclerosis. Researchers will assess convergent validity, intra-rater and inter-rater reliability, and calculate measurement error metrics such as SEM and MDC. Bland-Altman plots will be used to visualize agreement between raters. The study uses subtasks of counting backward in threes, verbal fluency, and ball-carrying on a tray to form the dual-task DTUG tests. Participants are adults with MS, 18–65, with EDSS 0–5.5, who do not use walking aids and meet other eligibility criteria, and the lead sponsor is Afyonkarahisar Health Sciences University in collaboration with SANKO University in Gaziantep, Turkey.
Why it matters
Potential benefit: If successful, clinicians could choose a validated and reliable DTUG protocol to better assess dual-task walking in MS and potentially guide fall-risk management.
How similar studies have gone: Previous research shows that dual-task assessments can be informative, but this study directly compares three DTUG protocols for reliability and validity in MS.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Having been diagnosed with MS according to the McDonald criteria revised in 2017, * Being between the ages of 18 and 65, * Having an Expanded Disability Status Scale (EDSS) score between 0 and 5.5, * Not requiring any assistive walking devices. Exclusion Criteria: * Pregnancy; * Having experienced a relapse within the past three months; * The presence of another neurological condition in addition to MS; * The presence of a different disorder that could potentially affect gait parameters; * The presence of visual, auditory, perceptual, or cognitive impairments severe enough to interfere with the test administration
Where it's running
-
SANKO University
Gaziantep, Turkey (Türkiye) Recruiting
Study contacts
- Principal investigator: Emel TAŞVURAN HORATA, PhD — Afyonkarahisar Health Sciences University
- Study coordinator: EMEL TAŞVURAN HORATA, PhD
- Email: ethorata@gmail.com
- Phone: 05547759663
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Treadmill-based virtual reality walking training for MS patients
This study tests whether a treadmill with virtual reality and smart socks can help people with multiple sclerosis walk better and feel safer in daily life.
-
Virtual Reality and Mental Practice to Improve Balance and Walking in Relapsing MS
This study tests whether virtual reality training or mental practice can improve balance and walking in people with relapsing–remitting multiple sclerosis.
-
REAL-MS: A Look at Autologous Stem Cell Transplant vs High-Efficacy MS Therapies in Real-World Care
This study tests how AHSCT compares to high-efficacy MS medicines in adults treated in routine clinical care.
-
Tolebrutinib in real-world MS care for patients treated by clinicians
This real-world study sees how tolebrutinib is used for multiple sclerosis patients and what outcomes look like in everyday practice.
-
Pilates via live video vs. prerecorded videos for people with multiple sclerosis
This study tests whether live, coach-led Pilates sessions through video calls are more beneficial than prerecorded Pilates videos for adults with MS.
-
Cooling During Inpatient Rehab for People with MS
This trial tests whether wearing a cooling vest during intensive training can reduce fatigue and improve walking, strength, balance, and cognition in people with multiple sclerosis during a 3-week inpatient rehab stay.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.